Anthracycline is a type of antibiotic that is extracted from numerous types of Streptomyces bacteria. They are used for the treatment of various types of cancer. It damages the DNA of cancer cells and stop its function. This can be done either by intercalating into the base pairs in the DNA minor grooves or by causing free radical damage of the ribose in the DNA. Daunorubicin, doxorubicin, and epirubicin are some of the top examples of anthracyclines.

The global Anthracyclines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Anthracyclines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthracyclines.

Report Scope

The Anthracyclines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anthracyclines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anthracyclines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Anthracyclines Market Report

Report Metric	Details
Report Name	Anthracyclines Market
CAGR	5%
Segment by Type	Oral Parenteral
Segment by Application	Leukemia Hodgkin Lymphoma Bladder Cancer Breast Cancer Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AstraZeneca, Sun Pharmaceutical Industries Ltd, Merck & Co., Inc, Lilly, Amgen Inc, GSK plc, Johnson & Johnson Services, Inc, Pfizer Inc, Meiji Holdings Co., Ltd, MicroBiopharm Japan Co., Ltd, Synbias Pharma, Hikma Pharmaceuticals PLC, Cumberland Pharmaceuticals Inc, Cadila Pharmaceuticals, Cipla Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anthracyclines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anthracyclines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anthracyclines Market report?

Ans: The main players in the Anthracyclines Market are AstraZeneca, Sun Pharmaceutical Industries Ltd, Merck & Co., Inc, Lilly, Amgen Inc, GSK plc, Johnson & Johnson Services, Inc, Pfizer Inc, Meiji Holdings Co., Ltd, MicroBiopharm Japan Co., Ltd, Synbias Pharma, Hikma Pharmaceuticals PLC, Cumberland Pharmaceuticals Inc, Cadila Pharmaceuticals, Cipla Inc

What are the Application segmentation covered in the Anthracyclines Market report?

Ans: The Applications covered in the Anthracyclines Market report are Leukemia, Hodgkin Lymphoma, Bladder Cancer, Breast Cancer, Other

What are the Type segmentation covered in the Anthracyclines Market report?

Ans: The Types covered in the Anthracyclines Market report are Oral, Parenteral

1 Anthracyclines Market Overview

1.1 Product Overview and Scope of Anthracyclines

1.2 Anthracyclines Segment by Type

1.2.1 Global Anthracyclines Market Value Comparison by Type (2024-2030)

1.2.2 Oral

1.2.3 Parenteral

1.3 Anthracyclines Segment by Application

1.3.1 Global Anthracyclines Market Value by Application: (2024-2030)

1.3.2 Leukemia

1.3.3 Hodgkin Lymphoma

1.3.4 Bladder Cancer

1.3.5 Breast Cancer

1.3.6 Other

1.4 Global Anthracyclines Market Size Estimates and Forecasts

1.4.1 Global Anthracyclines Revenue 2019-2030

1.4.2 Global Anthracyclines Sales 2019-2030

1.4.3 Global Anthracyclines Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Anthracyclines Market Competition by Manufacturers

2.1 Global Anthracyclines Sales Market Share by Manufacturers (2019-2024)

2.2 Global Anthracyclines Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Anthracyclines Average Price by Manufacturers (2019-2024)

2.4 Global Anthracyclines Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Anthracyclines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Anthracyclines, Product Type & Application

2.7 Anthracyclines Market Competitive Situation and Trends

2.7.1 Anthracyclines Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Anthracyclines Players Market Share by Revenue

2.7.3 Global Anthracyclines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anthracyclines Retrospective Market Scenario by Region

3.1 Global Anthracyclines Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Anthracyclines Global Anthracyclines Sales by Region: 2019-2030

3.2.1 Global Anthracyclines Sales by Region: 2019-2024

3.2.2 Global Anthracyclines Sales by Region: 2025-2030

3.3 Global Anthracyclines Global Anthracyclines Revenue by Region: 2019-2030

3.3.1 Global Anthracyclines Revenue by Region: 2019-2024

3.3.2 Global Anthracyclines Revenue by Region: 2025-2030

3.4 North America Anthracyclines Market Facts & Figures by Country

3.4.1 North America Anthracyclines Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Anthracyclines Sales by Country (2019-2030)

3.4.3 North America Anthracyclines Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Anthracyclines Market Facts & Figures by Country

3.5.1 Europe Anthracyclines Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Anthracyclines Sales by Country (2019-2030)

3.5.3 Europe Anthracyclines Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Anthracyclines Market Facts & Figures by Country

3.6.1 Asia Pacific Anthracyclines Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Anthracyclines Sales by Country (2019-2030)

3.6.3 Asia Pacific Anthracyclines Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Anthracyclines Market Facts & Figures by Country

3.7.1 Latin America Anthracyclines Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Anthracyclines Sales by Country (2019-2030)

3.7.3 Latin America Anthracyclines Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Anthracyclines Market Facts & Figures by Country

3.8.1 Middle East and Africa Anthracyclines Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Anthracyclines Sales by Country (2019-2030)

3.8.3 Middle East and Africa Anthracyclines Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Anthracyclines Sales by Type (2019-2030)

4.1.1 Global Anthracyclines Sales by Type (2019-2024)

4.1.2 Global Anthracyclines Sales by Type (2025-2030)

4.1.3 Global Anthracyclines Sales Market Share by Type (2019-2030)

4.2 Global Anthracyclines Revenue by Type (2019-2030)

4.2.1 Global Anthracyclines Revenue by Type (2019-2024)

4.2.2 Global Anthracyclines Revenue by Type (2025-2030)

4.2.3 Global Anthracyclines Revenue Market Share by Type (2019-2030)

4.3 Global Anthracyclines Price by Type (2019-2030)

5 Segment by Application

5.1 Global Anthracyclines Sales by Application (2019-2030)

5.1.1 Global Anthracyclines Sales by Application (2019-2024)

5.1.2 Global Anthracyclines Sales by Application (2025-2030)

5.1.3 Global Anthracyclines Sales Market Share by Application (2019-2030)

5.2 Global Anthracyclines Revenue by Application (2019-2030)

5.2.1 Global Anthracyclines Revenue by Application (2019-2024)

5.2.2 Global Anthracyclines Revenue by Application (2025-2030)

5.2.3 Global Anthracyclines Revenue Market Share by Application (2019-2030)

5.3 Global Anthracyclines Price by Application (2019-2030)

6 Key Companies Profiled

6.1 AstraZeneca

6.1.1 AstraZeneca Corporation Information

6.1.2 AstraZeneca Description and Business Overview

6.1.3 AstraZeneca Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.1.4 AstraZeneca Anthracyclines Product Portfolio

6.1.5 AstraZeneca Recent Developments/Updates

6.2 Sun Pharmaceutical Industries Ltd

6.2.1 Sun Pharmaceutical Industries Ltd Corporation Information

6.2.2 Sun Pharmaceutical Industries Ltd Description and Business Overview

6.2.3 Sun Pharmaceutical Industries Ltd Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Sun Pharmaceutical Industries Ltd Anthracyclines Product Portfolio

6.2.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates

6.3 Merck & Co., Inc

6.3.1 Merck & Co., Inc Corporation Information

6.3.2 Merck & Co., Inc Description and Business Overview

6.3.3 Merck & Co., Inc Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Merck & Co., Inc Anthracyclines Product Portfolio

6.3.5 Merck & Co., Inc Recent Developments/Updates

6.4 Lilly

6.4.1 Lilly Corporation Information

6.4.2 Lilly Description and Business Overview

6.4.3 Lilly Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Lilly Anthracyclines Product Portfolio

6.4.5 Lilly Recent Developments/Updates

6.5 Amgen Inc

6.5.1 Amgen Inc Corporation Information

6.5.2 Amgen Inc Description and Business Overview

6.5.3 Amgen Inc Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Amgen Inc Anthracyclines Product Portfolio

6.5.5 Amgen Inc Recent Developments/Updates

6.6 GSK plc

6.6.1 GSK plc Corporation Information

6.6.2 GSK plc Description and Business Overview

6.6.3 GSK plc Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.6.4 GSK plc Anthracyclines Product Portfolio

6.6.5 GSK plc Recent Developments/Updates

6.7 Johnson & Johnson Services, Inc

6.6.1 Johnson & Johnson Services, Inc Corporation Information

6.6.2 Johnson & Johnson Services, Inc Description and Business Overview

6.6.3 Johnson & Johnson Services, Inc Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Johnson & Johnson Services, Inc Anthracyclines Product Portfolio

6.7.5 Johnson & Johnson Services, Inc Recent Developments/Updates

6.8 Pfizer Inc

6.8.1 Pfizer Inc Corporation Information

6.8.2 Pfizer Inc Description and Business Overview

6.8.3 Pfizer Inc Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Pfizer Inc Anthracyclines Product Portfolio

6.8.5 Pfizer Inc Recent Developments/Updates

6.9 Meiji Holdings Co., Ltd

6.9.1 Meiji Holdings Co., Ltd Corporation Information

6.9.2 Meiji Holdings Co., Ltd Description and Business Overview

6.9.3 Meiji Holdings Co., Ltd Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Meiji Holdings Co., Ltd Anthracyclines Product Portfolio

6.9.5 Meiji Holdings Co., Ltd Recent Developments/Updates

6.10 MicroBiopharm Japan Co., Ltd

6.10.1 MicroBiopharm Japan Co., Ltd Corporation Information

6.10.2 MicroBiopharm Japan Co., Ltd Description and Business Overview

6.10.3 MicroBiopharm Japan Co., Ltd Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.10.4 MicroBiopharm Japan Co., Ltd Anthracyclines Product Portfolio

6.10.5 MicroBiopharm Japan Co., Ltd Recent Developments/Updates

6.11 Synbias Pharma

6.11.1 Synbias Pharma Corporation Information

6.11.2 Synbias Pharma Anthracyclines Description and Business Overview

6.11.3 Synbias Pharma Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Synbias Pharma Anthracyclines Product Portfolio

6.11.5 Synbias Pharma Recent Developments/Updates

6.12 Hikma Pharmaceuticals PLC

6.12.1 Hikma Pharmaceuticals PLC Corporation Information

6.12.2 Hikma Pharmaceuticals PLC Anthracyclines Description and Business Overview

6.12.3 Hikma Pharmaceuticals PLC Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Hikma Pharmaceuticals PLC Anthracyclines Product Portfolio

6.12.5 Hikma Pharmaceuticals PLC Recent Developments/Updates

6.13 Cumberland Pharmaceuticals Inc

6.13.1 Cumberland Pharmaceuticals Inc Corporation Information

6.13.2 Cumberland Pharmaceuticals Inc Anthracyclines Description and Business Overview

6.13.3 Cumberland Pharmaceuticals Inc Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Cumberland Pharmaceuticals Inc Anthracyclines Product Portfolio

6.13.5 Cumberland Pharmaceuticals Inc Recent Developments/Updates

6.14 Cadila Pharmaceuticals

6.14.1 Cadila Pharmaceuticals Corporation Information

6.14.2 Cadila Pharmaceuticals Anthracyclines Description and Business Overview

6.14.3 Cadila Pharmaceuticals Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Cadila Pharmaceuticals Anthracyclines Product Portfolio

6.14.5 Cadila Pharmaceuticals Recent Developments/Updates

6.15 Cipla Inc

6.15.1 Cipla Inc Corporation Information

6.15.2 Cipla Inc Anthracyclines Description and Business Overview

6.15.3 Cipla Inc Anthracyclines Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Cipla Inc Anthracyclines Product Portfolio

6.15.5 Cipla Inc Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Anthracyclines Industry Chain Analysis

7.2 Anthracyclines Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Anthracyclines Production Mode & Process

7.4 Anthracyclines Sales and Marketing

7.4.1 Anthracyclines Sales Channels

7.4.2 Anthracyclines Distributors

7.5 Anthracyclines Customers

8 Anthracyclines Market Dynamics

8.1 Anthracyclines Industry Trends

8.2 Anthracyclines Market Drivers

8.3 Anthracyclines Market Challenges

8.4 Anthracyclines Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Sun Pharmaceutical Industries Ltd.

Johnson & Johnson Services Inc.

Pfizer Inc

Meiji Holdings Co. Ltd.

Synbias Pharma

Hikma Pharmaceuticals PLC

Cumberland Pharmaceuticals Inc

Cadila Pharmaceuticals

Cipla Ltd

MicroBiopharm Japan Co., Ltd

List of Tables

Table 1. Global Anthracyclines Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Anthracyclines Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Anthracyclines Market Competitive Situation by Manufacturers in 2023

Table 4. Global Anthracyclines Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Anthracyclines Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Anthracyclines Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Anthracyclines Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Anthracyclines Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Anthracyclines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Anthracyclines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Anthracyclines, Product Type & Application

Table 12. Global Key Manufacturers of Anthracyclines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Anthracyclines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthracyclines as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Anthracyclines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Anthracyclines Sales by Region (2019-2024) & (K Units)

Table 18. Global Anthracyclines Sales Market Share by Region (2019-2024)

Table 19. Global Anthracyclines Sales by Region (2025-2030) & (K Units)

Table 20. Global Anthracyclines Sales Market Share by Region (2025-2030)

Table 21. Global Anthracyclines Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Anthracyclines Revenue Market Share by Region (2019-2024)

Table 23. Global Anthracyclines Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Anthracyclines Revenue Market Share by Region (2025-2030)

Table 25. North America Anthracyclines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Anthracyclines Sales by Country (2019-2024) & (K Units)

Table 27. North America Anthracyclines Sales by Country (2025-2030) & (K Units)

Table 28. North America Anthracyclines Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Anthracyclines Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Anthracyclines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Anthracyclines Sales by Country (2019-2024) & (K Units)

Table 32. Europe Anthracyclines Sales by Country (2025-2030) & (K Units)

Table 33. Europe Anthracyclines Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Anthracyclines Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Anthracyclines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Anthracyclines Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Anthracyclines Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Anthracyclines Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Anthracyclines Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Anthracyclines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Anthracyclines Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Anthracyclines Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Anthracyclines Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Anthracyclines Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Anthracyclines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Anthracyclines Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Anthracyclines Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Anthracyclines Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Anthracyclines Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Anthracyclines Sales (K Units) by Type (2019-2024)

Table 51. Global Anthracyclines Sales (K Units) by Type (2025-2030)

Table 52. Global Anthracyclines Sales Market Share by Type (2019-2024)

Table 53. Global Anthracyclines Sales Market Share by Type (2025-2030)

Table 54. Global Anthracyclines Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Anthracyclines Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Anthracyclines Revenue Market Share by Type (2019-2024)

Table 57. Global Anthracyclines Revenue Market Share by Type (2025-2030)

Table 58. Global Anthracyclines Price (US$/Unit) by Type (2019-2024)

Table 59. Global Anthracyclines Price (US$/Unit) by Type (2025-2030)

Table 60. Global Anthracyclines Sales (K Units) by Application (2019-2024)

Table 61. Global Anthracyclines Sales (K Units) by Application (2025-2030)

Table 62. Global Anthracyclines Sales Market Share by Application (2019-2024)

Table 63. Global Anthracyclines Sales Market Share by Application (2025-2030)

Table 64. Global Anthracyclines Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Anthracyclines Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Anthracyclines Revenue Market Share by Application (2019-2024)

Table 67. Global Anthracyclines Revenue Market Share by Application (2025-2030)

Table 68. Global Anthracyclines Price (US$/Unit) by Application (2019-2024)

Table 69. Global Anthracyclines Price (US$/Unit) by Application (2025-2030)

Table 70. AstraZeneca Corporation Information

Table 71. AstraZeneca Description and Business Overview

Table 72. AstraZeneca Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. AstraZeneca Anthracyclines Product

Table 74. AstraZeneca Recent Developments/Updates

Table 75. Sun Pharmaceutical Industries Ltd Corporation Information

Table 76. Sun Pharmaceutical Industries Ltd Description and Business Overview

Table 77. Sun Pharmaceutical Industries Ltd Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Sun Pharmaceutical Industries Ltd Anthracyclines Product

Table 79. Sun Pharmaceutical Industries Ltd Recent Developments/Updates

Table 80. Merck & Co., Inc Corporation Information

Table 81. Merck & Co., Inc Description and Business Overview

Table 82. Merck & Co., Inc Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Merck & Co., Inc Anthracyclines Product

Table 84. Merck & Co., Inc Recent Developments/Updates

Table 85. Lilly Corporation Information

Table 86. Lilly Description and Business Overview

Table 87. Lilly Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Lilly Anthracyclines Product

Table 89. Lilly Recent Developments/Updates

Table 90. Amgen Inc Corporation Information

Table 91. Amgen Inc Description and Business Overview

Table 92. Amgen Inc Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Amgen Inc Anthracyclines Product

Table 94. Amgen Inc Recent Developments/Updates

Table 95. GSK plc Corporation Information

Table 96. GSK plc Description and Business Overview

Table 97. GSK plc Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. GSK plc Anthracyclines Product

Table 99. GSK plc Recent Developments/Updates

Table 100. Johnson & Johnson Services, Inc Corporation Information

Table 101. Johnson & Johnson Services, Inc Description and Business Overview

Table 102. Johnson & Johnson Services, Inc Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Johnson & Johnson Services, Inc Anthracyclines Product

Table 104. Johnson & Johnson Services, Inc Recent Developments/Updates

Table 105. Pfizer Inc Corporation Information

Table 106. Pfizer Inc Description and Business Overview

Table 107. Pfizer Inc Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Pfizer Inc Anthracyclines Product

Table 109. Pfizer Inc Recent Developments/Updates

Table 110. Meiji Holdings Co., Ltd Corporation Information

Table 111. Meiji Holdings Co., Ltd Description and Business Overview

Table 112. Meiji Holdings Co., Ltd Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Meiji Holdings Co., Ltd Anthracyclines Product

Table 114. Meiji Holdings Co., Ltd Recent Developments/Updates

Table 115. MicroBiopharm Japan Co., Ltd Corporation Information

Table 116. MicroBiopharm Japan Co., Ltd Description and Business Overview

Table 117. MicroBiopharm Japan Co., Ltd Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. MicroBiopharm Japan Co., Ltd Anthracyclines Product

Table 119. MicroBiopharm Japan Co., Ltd Recent Developments/Updates

Table 120. Synbias Pharma Corporation Information

Table 121. Synbias Pharma Description and Business Overview

Table 122. Synbias Pharma Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Synbias Pharma Anthracyclines Product

Table 124. Synbias Pharma Recent Developments/Updates

Table 125. Hikma Pharmaceuticals PLC Corporation Information

Table 126. Hikma Pharmaceuticals PLC Description and Business Overview

Table 127. Hikma Pharmaceuticals PLC Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Hikma Pharmaceuticals PLC Anthracyclines Product

Table 129. Hikma Pharmaceuticals PLC Recent Developments/Updates

Table 130. Cumberland Pharmaceuticals Inc Corporation Information

Table 131. Cumberland Pharmaceuticals Inc Description and Business Overview

Table 132. Cumberland Pharmaceuticals Inc Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Cumberland Pharmaceuticals Inc Anthracyclines Product

Table 134. Cumberland Pharmaceuticals Inc Recent Developments/Updates

Table 135. Cadila Pharmaceuticals Corporation Information

Table 136. Cadila Pharmaceuticals Description and Business Overview

Table 137. Cadila Pharmaceuticals Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Cadila Pharmaceuticals Anthracyclines Product

Table 139. Cadila Pharmaceuticals Recent Developments/Updates

Table 140. Cipla Inc Corporation Information

Table 141. Cipla Inc Description and Business Overview

Table 142. Cipla Inc Anthracyclines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Cipla Inc Anthracyclines Product

Table 144. Cipla Inc Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Anthracyclines Distributors List

Table 148. Anthracyclines Customers List

Table 149. Anthracyclines Market Trends

Table 150. Anthracyclines Market Drivers

Table 151. Anthracyclines Market Challenges

Table 152. Anthracyclines Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Anthracyclines

Figure 2. Global Anthracyclines Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Anthracyclines Market Share by Type in 2023 & 2030

Figure 4. Oral Product Picture

Figure 5. Parenteral Product Picture

Figure 6. Global Anthracyclines Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Anthracyclines Market Share by Application in 2023 & 2030

Figure 8. Leukemia

Figure 9. Hodgkin Lymphoma

Figure 10. Bladder Cancer

Figure 11. Breast Cancer

Figure 12. Other

Figure 13. Global Anthracyclines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Anthracyclines Market Size (2019-2030) & (US$ Million)

Figure 15. Global Anthracyclines Sales (2019-2030) & (K Units)

Figure 16. Global Anthracyclines Average Price (US$/Unit) & (2019-2030)

Figure 17. Anthracyclines Report Years Considered

Figure 18. Anthracyclines Sales Share by Manufacturers in 2023

Figure 19. Global Anthracyclines Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Anthracyclines Players: Market Share by Revenue in 2023

Figure 21. Anthracyclines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Anthracyclines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Anthracyclines Sales Market Share by Country (2019-2030)

Figure 24. North America Anthracyclines Revenue Market Share by Country (2019-2030)

Figure 25. United States Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Anthracyclines Sales Market Share by Country (2019-2030)

Figure 28. Europe Anthracyclines Revenue Market Share by Country (2019-2030)

Figure 29. Germany Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Anthracyclines Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Anthracyclines Revenue Market Share by Region (2019-2030)

Figure 36. China Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Anthracyclines Sales Market Share by Country (2019-2030)

Figure 44. Latin America Anthracyclines Revenue Market Share by Country (2019-2030)

Figure 45. Mexico Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Anthracyclines Sales Market Share by Country (2019-2030)

Figure 49. Middle East & Africa Anthracyclines Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE Anthracyclines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Anthracyclines by Type (2019-2030)

Figure 54. Global Revenue Market Share of Anthracyclines by Type (2019-2030)

Figure 55. Global Anthracyclines Price (US$/Unit) by Type (2019-2030)

Figure 56. Global Sales Market Share of Anthracyclines by Application (2019-2030)

Figure 57. Global Revenue Market Share of Anthracyclines by Application (2019-2030)

Figure 58. Global Anthracyclines Price (US$/Unit) by Application (2019-2030)

Figure 59. Anthracyclines Value Chain

Figure 60. Anthracyclines Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Distributors Profiles

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions